NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1 – DESCRIPTION OF OPERATIONS
Sharing
Services Global Corporation and subsidiaries (“Sharing Services”, “we,” or the “Company”)
is a publicly traded company that aims to build shareholder value by developing or acquiring businesses that augment the Company’s
product and services portfolio, business competencies, and geographic reach.
Currently,
the Company markets and distributes its health and wellness and other products primarily in the United States, Canada and the
Asia Pacific region. Through its subsidiaries, the Company currently markets its products and services primarily through an independent
sales force, using a direct selling business model. The Company does not currently operate
retail stores. It markets its products and services through its independent sales force, using its proprietary websites,
including: www.elevacity.com and www.thehappyco.com and using social media.
The
Company is an emerging growth company and was incorporated in the State of Nevada in April 2015. The
Company recently changed its fiscal year, from a fiscal year ending on April 30 to a fiscal year ending on March 31.
Corporate
Name Change
Sharing
Services Global Corporation was originally incorporated under the name Sharing Services, Inc. In January 2019, Sharing Services,
Inc. changed its corporate name to Sharing Services Global Corporation to better reflect the Company’s strategic intent
to grow its business globally. In connection with the name change, the Company adopted the trading symbol SHRG effective April
4, 2019. Prior to this the Company’s Common Stock traded under the symbol SHRV.
Change
of Fiscal Year
In
March 2021, the Company adopted a change in its fiscal year end from a fiscal year ending on April 30 to a fiscal year ending
on March 31. The adoption of a new fiscal year end was pursuant to a prior authorization by the Company’s Board of Directors.
The Company believes that adoption of a fiscal year ending on March 31 will enhance the usefulness and comparability of information
reported about the Company’s financial position and results of operations by aligning such information more closely with
that of other public reporting entities.
The
following table sets forth certain information about the Company’s results of operations for the eleven (11) months ended
March 31, 2021 and 2020. The information for the eleven (11) months ended March 31, 2020, represents unaudited pro-forma information.
|
|
11 Months Ended March 31,
|
|
|
|
2021
|
|
|
2020
|
|
Net sales
|
|
$
|
64,811,151
|
|
|
$
|
121,613,476
|
|
Gross Profit
|
|
$
|
46,546,657
|
|
|
$
|
86,445,680
|
|
Income (loss) from continuing operations
|
|
$
|
(1,829,530
|
)
|
|
$
|
994,102
|
|
Earnings (loss) before income taxes
|
|
$
|
(1,829,530
|
)
|
|
$
|
994,102
|
|
Provision for (benefit from) income taxes
|
|
|
(594,509
|
)
|
|
|
444,058
|
|
Net earnings (loss)
|
|
$
|
(1,235,021
|
)
|
|
$
|
550,044
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share
|
|
$
|
(0.01
|
)
|
|
$
|
0.00
|
|
Diluted earnings (loss) per share
|
|
$
|
(0.01
|
)
|
|
$
|
0.00
|
|
NOTE
2 – SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the
United States (“GAAP”) and include the accounts of the Company and its consolidated subsidiaries. All significant
intercompany accounts and transactions have been eliminated in consolidation. Currently, all the Company’s consolidated
subsidiaries are wholly owned and have a fiscal year consistent with the Company’s fiscal year. To date, foreign currency
fluctuations are not material to the Company’s consolidated financial statements.
Reclassifications
Certain
reclassifications have been made to the prior year data to conform with the current period’s presentation.
Comprehensive
Income
For
the fiscal periods covered by this Transition Report, the only material component of the Company’s comprehensive income
(loss) is the Company’s net earnings (loss). Accordingly, the Company does not present a consolidated statement of comprehensive
income.
Correction
of Errors
In
its fiscal quarter ended January 31, 2021, the Company identified two errors in amounts previously reported in its Quarterly Reports
on Form 10-Q for the interim periods ended July 31, 2020 and October 31, 2020 concerning the method used to capitalize work-in-progress
for projects and errors in its stock-based compensation expense related to employment contracts. Accordingly, the Company made
the following corrections to previously reported amounts:
Capitalization
of Costs for Ongoing Projects and Development of a New Business Brand. - In the fiscal quarter ended January 31, 2021, the
Company capitalized costs incurred in connection with ongoing upgrades to its information technology systems, the development
of the new business brand “The Happy Co ™” and office renovations, in the aggregate, of $816,116. Of the amount
capitalized in the current quarter, $58,038 should have been capitalized in the quarter ended July 31, 2020 and $469,219 should
have been capitalized in the quarter ended October 31, 2020.
Stock-based
Compensation Expense - In the fiscal quarter ended January 31, 2021, the Company conducted a detailed review of the terms
and conditions of stock warrants awarded to its employees in connection with employment agreements. As a result of this review,
the Company concluded that stock-based compensation expense reported in the quarter ended July 31, 2020 was understated, before
income taxes, by approximately $5,587 and stock-based compensation expense reported in the quarter ended October 31, 2020 was
overstated, before income taxes, by $80,981. See Note 14 – “Stock-Based Compensation – Stock Warrants”
for additional details and changes in presentation.
The
impact on our previously reported Net Earnings for the affected periods is:
|
|
For the Three Months Ended July 31, 2020
|
|
|
For the Three Months Ended October 31, 2020
|
|
|
For the Six Months Ended October 31, 2020
|
|
Net Earnings/(Loss) – As Reported
|
|
$
|
(1,093,377
|
)
|
|
$
|
1,851,356
|
|
|
$
|
757,979
|
|
Adjustments (net of tax):
|
|
|
|
|
|
|
|
|
|
|
|
|
Capitalized Projects
|
|
|
50,264
|
|
|
|
306,708
|
|
|
|
356,972
|
|
Warrant Benefit / (Expense)
|
|
|
(5,587
|
)
|
|
|
80,981
|
|
|
|
75,394
|
|
Total Adjustments
|
|
|
44,677
|
|
|
|
387,689
|
|
|
|
432,366
|
|
Net Earnings/(Loss) – As Corrected
|
|
$
|
(1,048,700
|
)
|
|
$
|
2,239,045
|
|
|
$
|
1,190,345
|
|
The
Company has identified the impacted internal controls for both errors and has implemented additional internal controls in order
to identify and mitigate in the future.
Use
of Estimates and Assumptions
The
preparation of financial statements in accordance with GAAP requires the use of judgment and requires management to make estimates
and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent
assets and liabilities, if any. Matters that require the use of estimates and assumptions include, among others: the recoverability
of accounts receivable, the valuation of inventory, the useful lives of fixed assets, the assessment of long-lived assets for
impairment, the nature and timing of satisfaction of multiple performance obligations resulting from contracts with customers,
the allocation of the transaction price to multiple performance obligations in a sales transaction, the measurement and recognition
of right-of-use assets and related lease liabilities, the valuation of share-based compensation awards, the provision for income
taxes, the measurement and recognition of uncertain tax positions, and the valuation of loss contingencies, if any. Actual results
may differ from these estimates in amounts that may be material to our consolidated financial statements. We believe that the
estimates and assumptions used in the preparation of our consolidated financial statements are reasonable.
Cash
and cash equivalents
Cash
and cash equivalents include cash on hand, demand deposits in banking institutions, and cash equivalents, if any. As of March
31, 2021, and April 30, 2020, cash and cash equivalents also include $6.2 million and $11.1 million, respectively, of deposits
with our merchant processors, consisting of proceeds from recent sales transactions, which are unrestricted and are not insured
by any federal agency.
Cash
equivalents, if any, represent highly liquid short-term investments with an original maturity of 90 days or less and are stated
at cost, which approximates fair value.
Accounts
Receivable and Allowance for Doubtful Accounts
As
of March 31, 2021 and April 30, 2020, accounts receivable consists primarily of amounts due from our merchant processors, including
$1.5 million and $4.0 million, respectively, receivable from one merchant processor. We assess the adequacy of our allowance for
doubtful accounts, if any, on the basis of our historical collection data and current information. Account balances are written
off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Inventory
and Cost of Goods Sold
Inventory
consists of product held for sale in the normal course of our business. Inventory is stated at the lower of cost, determined using
the first-in, first-out (“FIFO”) method, or net realizable value. Inventory cost reflects direct product costs and
certain shipping and handling costs, such as in-bound freight. When estimating the net realizable value of inventory, we consider
several factors including estimates of future demand for the product, historical turn-over rates, the age and sales history of
the inventory, and historic and anticipated changes in our product offerings.
Physical
inventory counts are performed at all facilities at least annually. Upon completion of physical inventory counts, our consolidated
financial statements are adjusted to reflect actual quantities on hand. Between physical counts, we estimate inventory shrinkage
based on our historical experience. The Company periodically assesses its inventory levels when compared to current and anticipated
sales levels. During the fiscal year ended March 31, 2021, the Company recognized a provision for excess (slow-moving) or obsolete
inventory of $1.1 million in connection with health and wellness product that is damaged, expired or otherwise in excess of forecasted
outputs, based on our current and anticipated sales levels. The Company reports its provisions for inventory losses in cost of
goods sold in its consolidated statements of operations.
Cost
of goods sold includes actual product costs, vendor rebates and allowances, if any, inventory shrinkage and certain shipping and
handling costs, such as in-bound freight, associated with product sold. All other shipping and handling costs, including the cost
to ship product to customers, are included in selling and marketing expenses in our consolidated statements of operations when
incurred.
Property
and Equipment
Property
and equipment are recorded at cost and reported net of accumulated depreciation. Depreciation expense is recognized over an asset’s
estimated useful life using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful
lives of the assets or the term of the related lease, including lease renewals considered reasonably assured. The estimated useful
lives of our property and equipment are as follows:
|
●
|
Furniture
and fixtures – 3 years
|
|
●
|
Office
equipment – 5 years
|
|
●
|
Computer
Equipment – 3 years
|
|
●
|
Computer
software – 3 years
|
|
●
|
Leasehold
improvements – 3 years
|
The
estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. The recoverability of
long-lived assets is assessed for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be fully recoverable, by comparing the net carrying amount of each asset to the total estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its undiscounted future cash
flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair
value of the asset.
Revenue
Recognition
The
Company recognizes revenue net of amounts due to taxing authorities (such as local and state sales tax). Our customers place sales
orders online and through our “back-office” operations, which creates a contract and establishes the transaction price.
The Company recognizes revenue when (or as) it transfers control of the promised goods and services to the customer. With respect
to products sold, our performance obligation is satisfied upon receipt of the products by the customer. With respect to subscription-based
revenue, including independent distributor membership fees, our performance obligation is satisfied over time (generally, up to
one year). The timing of our revenue recognition may differ from the time when we invoice the customer and/or collect payment.
The Company has elected to treat shipping and handling costs as an activity to fulfill its performance obligations, rather than
a separate performance obligation.
As
of March 31, 2021, and April 30, 2020, deferred revenue associated with product invoiced but not received by customers at the
balance sheet date was $1.2 million and $2.7 million, deferred revenue associated with unfulfilled performance obligations for
services offered on a subscription basis was $153,216 and $433,386, and deferred sales revenue associated with unfulfilled performance
obligations for customers’ right of return was $95,780 and $263,117, respectively. Our deferred sales revenue amounts are
expected to be recognized over one year.
During
the fiscal year ended March 31, 2021 and April 30, 2020, no individual customer, or related group of customers, represents 10%
or more of our consolidated net sales. During the fiscal year ended March 31, 2021, approximately 71% of our net sales were to
customers (including 43% to recurring customers, which we refer to as “SmartShip” sales, and approximately 28% to
new customers) and approximately 29% of our net sales were to our independent distributors. During the fiscal year ended April
30, 2020, approximately 73% of our consolidated net sales were to customers (including approximately 47% of our consolidated net
sales were to recurring customers, which we refer to as “SmartShip” sales, and approximately 26% were to new customers)
and approximately 27% were to our independent distributors.
During
the fiscal year ended March 31, 2021 and April 30, 2020, approximately 94% and 95%, respectively, of our consolidated net sales
are to our customers and independent distributors located in the United States.
During
the fiscal year ended March 31, 2021, approximately 99% of our consolidated net sales are from our health and wellness products
(including approximately 53% from the sale of Nutraceutical products, approximately 17% from the sale of coffee and coffee-related
products, and approximately 31% from the sale of all other health and wellness products). During the fiscal year ended April 30,
2020, approximately 98% of our consolidated net sales are from our health and wellness products (including approximately 54% from
the sale of Nutraceutical products, approximately 24% from the sales of coffee and coffee-related products, and approximately
22% from the sale of all other health and wellness products). During the fiscal year ended March 31, 2021, our ten top selling
products represent approximately 54% of our consolidated net sales.
During
the fiscal year ended March 31, 2021, and April 30, 2020, product purchases from one supplier accounted for approximately 99%
and 98%, respectively, of our total product purchases.
Sales
Commissions
The
Company recognizes sales commission expense when incurred. In the fiscal year ended March 31, 2021, and April 30, 2020, sales
commission expense was $29.4 million and $59.0 million, respectively, and is included in selling and marketing expenses in our
consolidated statements of operations.
In
the fiscal year ended March 31, 2021, the Company issued to members of its independent sales force who had been offered stock
warrants under the 2019 Sales-Related Warrants program discussed below and met other qualifications (mainly related to remaining
active distributors), fully vested warrants to purchase up to 4,013,000 shares its Common Stock with an estimated aggregate fair
value of $1.5 million (the “2020 Sales-Related Warrants”). The 2020 Sales-Related Warrants are exercisable for a period
of one year from the issuance date at the exercise price of $0.01 per share. At the time of issuance, the rights conferred by
the 2020 Sales-Related Warrants were not subject to service conditions and all other conditions necessary to earn the award had
been satisfied. The Company deems the fair value of the warrants granted to members of its independent contractor sales force
to be an element of sales compensation expense and, as such, includes this expense in selling and marketing expenses in its consolidated
statements of operations. The rights conferred by the 2020 Sales-Related Warrants program were contingent on the warrant holder
releasing the Company form future obligation under the 2019 Sales-Related Warrants program, including in the case where the warrant
holder had not formally accepted the 2019 Sales-Related Warrant. When the warrant holder had not accepted the 2019 Sales-Related
Warrant, the Company recognized sales compensation expense ($1.5 million) in connection with stock warrants issued under the 2020
Sales-Related Warrants program to participants of the predecessor plan who accepted the new award. When the warrant holder had
accepted the 2019 Sales-Related Warrant, the Company recognized incremental sales compensation expense of $140,911 in connection
with unexercised equity-based awards under the 2019 Sales-Related Warrants program that were deemed modified, as defined by GAAP,
by the new award.
In
the fiscal year ended April 30, 2019, the Company had offered to members of its independent sales force who had met certain sales
targets, fully vested warrants to purchase up to 11,000,000 shares its Common Stock (the “2019 Sales-Related Warrants”).
The warrants are exercisable for a period of two years from the issuance date at the exercise price of $0.25 per share. The rights
conferred by the warrants were not subject to service conditions and all other conditions necessary to earn the award have been
satisfied. In accordance with GAAP, in the fiscal year ended March 31, 2021, the Company derecognized sales compensation expense
of $1.1 million in connection with stock warrants previously offered under the 2019 Sales-Related Warrants program that expired
or were terminated or otherwise forfeited.
As
of March 31, 2021, and April 30, 2020, accrued sales commission payable was $4,713,777 and $7,983,536, respectively, including
$0 and $1,290,477, respectively, in estimated sales compensation contingently payable with stock warrants under the 2019 Sales-Related
Warrants program.
Share-Based
Payments
The
Company accounts for stock-based compensation awards to its directors, officers, and employees in accordance with Accounting Standards
Codification (“ASC”) Topic 718, Compensation – Stock Compensation (“ASC 718”). During the
fiscal year ended April 30, 2020, the Company, through a subsidiary, entered into multi-year employment agreements with certain
employees. In general, each employment agreement contains (a) an Initial Warrant that vested immediately and is exercisable at
a fixed exercise price and (b) Subsequent Warrants that vest over time and are exercisable at an exercise price calculated by
multiplying a specified discount rate by the 10-day average stock price determined at the time of exercise. Generally, a Subsequent
Warrants tranche vests in full at each anniversary of the employment agreement effective date, during the contractual term of
employment. The Company believes that it is useful to disclose information concerning the subsequent warrants that are anticipated
to vest during the contractual period of the employment. Based on that belief, in the interim period ended January 31, 2021, the
Company changed its presentation of warrants outstanding at the end of any period to include those unvested Subsequent Warrants.
As
stated above, some stock warrants issued in connection with these multi-year employment agreements are exercisable at a variable
exercise price, a price equal to the discounted 10-day average stock price determined at the time of exercise. In general, the
Company begins recognizing the compensatory nature of the warrants at the service inception date and ceases recognition at the
vesting date. Due to the variable nature of the exercise price for some grants, however, the Company remeasures compensation expense
associated with these awards after the service period ends and until the warrant is exercised or expires. As such, the Company’s
stock-based compensation expense contains components associated with (i) awards that have a fixed exercise price whose fair value
is measured at the grant date and (ii) awards with a variable exercise price whose value is measured at the balance sheet date,
including fully vested awards. The Company recognizes the income/expense component associated with the subsequent measure of fully
vested awards as non-operating income/expense.
The
Company accounts for stock-based compensation awards to non-employees, in accordance with ASC 718, as amended. In June 2018, the
Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-07,
Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee Share-based Payment Accounting
which extended the provisions of ASC 718 to share-based awards issued to non-employees by public companies. The Company has adopted
the provisions of ASU 2018-07. In the fiscal year ended March 31, 2021 and April 30, 2020, sales commission expense includes $558,629
and $20,216, respectively, in connection sales-related stock warrants (see Sales Commissions above).
Lease
Accounting
The
Company accounts for its lease obligations in accordance with ASC Topic 842, Leases (“ASC 842”), which requires
lessees to report on their balance sheets a right-of-use asset and a lease liability in connection with most lease agreements
classified as operating leases. ASC 842 requires that leases be classified at inception as either (a) operating leases or (b)
finance leases. For operating leases, periodic expense generally is flat (straight-line) throughout the life of the lease. For
finance leases, periodic expense declines over the life of the lease. The Company adopted the provisions of ASC 842 in its fiscal
year ended April 30, 2020, and adoption resulted in an initial lease liability of approximately $1.4 million and a right to use
asset in the same amount. The adoption of ASC 842 did not otherwise have a material impact on the Company’s consolidated
financial statements.
The
Company leases space for its corporate headquarters, additional office and warehouse space, automobiles, and office and other
equipment, under lease agreements classified as operating leases, under ASC 842. See Note 11 – “LEASES” below
for more information about the Company’s lease obligations.
Foreign
Currency
During
the fiscal year ended March 31, 2021, and April 30, 2020, 94% and 95%, respectively, of our consolidated net sales are to customers
and independent distributors located in the U.S. (based on the customer’s shipping address). As part of its growth initiatives,
the Company is in the process of expanding operations outside the United States. The functional currency of each of our foreign
operations is generally the respective local currency. Balance sheet accounts are translated into U.S. dollars (our reporting
currency) at the rates of exchange in effect at the balance sheet date, while the results of operations and cash flows are generally
translated using average exchange rates for the periods presented. Individually material transactions, if any, are translated
using the actual rate of exchange on the transaction date. The resulting translation adjustments, if any, are recorded as a component
of accumulated other comprehensive loss in our consolidated balance sheets.
Income
Taxes
The
Company uses the asset and liability method in accounting for income taxes. We recognize deferred tax assets and liabilities for
the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases (“temporary differences”). Deferred tax assets and liabilities
are measured using enacted tax rates expected to apply in the years in which temporary differences are anticipated to be recovered
or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in measuring results of operations
in the period that includes the enactment date. Deferred tax assets are evaluated periodically, and a valuation allowance is recorded
to reduce the carrying amounts of deferred tax assets to the amount expected to be realized unless it is more-likely-than-not
that the assets will be realized in full. When assessing whether it is more-likely-than-not that the deferred tax assets will
be realized, management considers multiple factors, including recent earnings history, expectations of future earnings, available
carryforward periods, the availability of tax planning strategies, and other relevant quantitative and qualitative factors.
In
determining the provision for income taxes, an annual effective income tax rate is used based on annual income, permanent differences
between book and tax income, and statutory income tax rates. Accounting for income taxes involves judgment and the use of estimates.
The
Company recognizes a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken
in its tax returns, unless the weight of available evidence indicates it is more-likely-than-not that the tax position will be
sustained on audit, including resolution through available appeals processes. We measure the tax position as the largest amount
which is more-likely-than-not of being realized. The Company considers many factors when evaluating and estimating the Company’s
tax positions, which may require periodic adjustments when new facts and circumstances become known. See Note 12 – “Income
Taxes” for more information about the Company’s accounting for income taxes.
Recently
Issued Accounting Standards - Adopted
In
November 2019, the FASB issued ASU No. 2019-08, Compensation – Stock Compensation (Topic 718) and Revenue from Contracts
with Customers (Topic 606): Codification Improvements – Share-based Consideration Payable to a Customer (“ASU
2019-08”). ASU 2019-08 requires that an entity apply the guidance in ASC 718 to measure and classify share-based payment
awards granted to a customer. Under ASC 718, among other things, share-based awards to non-employees (including customers) must
generally be measured at the grant-date fair value of the equity instrument. For entities that have adopted the provisions of
ASU 2018-07, Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee Share-based Payment Accounting,
this amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.
As discussed in Note 2, the Company has adopted the provisions of ASU 2018-07. Accordingly, the Company adopted the provisions
of ASU 2019-08 effective on May 1, 2020 and such adoption did not have a material impact on its consolidated financial statements.
In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) which modifies the disclosure requirements
about fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (“ASC 820”). For
public companies, ASU 2018-13 removes the prior requirement to disclose: (a) the amount and reason for transfers between Level
1 and Level 2 of the fair value hierarchy contained in ASC 820, (b) the policy for timing of transfers between levels, and (c)
the valuation processes used for level 3 fair value measurements. For public companies, ASU 2018-13 also adds, among other things,
a requirement to disclose the range and weighted average of significant unobservable inputs used in Level 3 fair value measurements.
The Company adopted the provisions of ASU 2018-13 effective on February 1, 2020 and such adoption did not have a material impact
on its consolidated financial statements.
Recently
Issued Accounting Standards - Pending Adoption
In
August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives
and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible
instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host
contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not
result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method
when calculating the impact of convertible instruments on diluted Earnings per Share. For the Company, the provisions of ASU 2020-06
are effective for its fiscal quarter beginning on May 1, 2024. Early adoption is permitted, subject to certain limitations. The
Company is evaluating the potential impact of adoption on its consolidated financial statements.
In
December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes
(“ASU 2019-12”). ASU 2019-12, among other things, (a) eliminates the exception to the incremental approach for
intra-period tax allocation when there is a loss from continuing operations and income (or a gain) from other items, (b) eliminates
the exception to the general methodology for calculating income taxes in an interim period when the year-to-date loss exceeds
the anticipated loss for the year, (c) requires than an entity recognize a franchise tax (or a similar tax) that is partially
based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax, and (d) requires
than an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation for the
interim period that includes the enactment date. For public companies, these amendments are effective for fiscal years, and interim
periods within those fiscal years, that begin after December 15, 2020. The Company will adopt ASU 2019-12 effective April 1, 2021
and based on its preliminary evaluation it does not believe adoption will have a material impact on its consolidated financial
statements.
NOTE
3 – FAIR VALUE MEASURMENTS
Our
financial instruments consist of cash equivalents, if any, accounts receivable, notes receivable, investments in unconsolidated
entities, accounts payable, and notes payable, including convertible notes. The carrying amounts of cash equivalents, if any,
accounts receivable, notes receivable, and accounts payable approximate their respective fair values due to the short-term nature
of these financial instruments.
We
measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC 820, as amended.
We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e.,
the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level
hierarchy for measuring fair value and requires entities to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. There were no transfers between the levels of the fair value hierarchy during the periods covered
by the accompanying consolidated financial statements.
Consistent
with the valuation hierarchy contained in ASC 820, we categorized certain of our financial assets and liabilities as follows:
|
|
March
31, 2021
|
|
|
|
Total
|
|
|
Level
1
|
|
|
Level
2
|
|
|
Level
3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
receivable
|
|
$
|
94,600
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
94,600
|
|
Investments
in unconsolidated entities
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total
assets
|
|
$
|
94,600
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
94,600
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes
Payable
|
|
$
|
1,040,400
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,040,400
|
|
Convertible
notes payable
|
|
|
134,393
|
|
|
|
-
|
|
|
|
-
|
|
|
|
134,393
|
|
Total
liabilities
|
|
$
|
1,174,793
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1,174,793
|
|
|
|
April 30, 2020
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes receivable
|
|
$
|
118,047
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
118,047
|
|
Investments in unconsolidated entities
|
|
|
20,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
20,000
|
|
Total assets
|
|
$
|
138,047
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
138,047
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable
|
|
$
|
115,745
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
115,745
|
|
Notes payable
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total liabilities
|
|
$
|
115,745
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
115,745
|
|
The
Company’s investments in unconsolidated entities are reported at cost in its consolidated financial statements. The investments
are valued for purposes of this disclosure using unobservable inputs, since there are no observable market transactions for such
investments. The fair value of notes receivable approximates the carrying value due to the short-term nature of the note. See
Note 5 below for more information about our notes receivable.
At
March 31, 2021 and April 30, 2020, convertible notes payable (including current maturities) are reported in our consolidated financial
statements at amortized cost of $150,000, less unamortized debt discount of $15,607 and $34,255, respectively. Our notes and convertible
notes payable are valued for purposes of this disclosure using discounted cash flows and observable interest rates whenever available.
There are no observable market transactions for our notes and convertible notes. See Notes 8 and 10 below for more information
about our notes and convertible notes payable.
NOTE
4 – EARNINGS (LOSS) PER SHARE
We
calculate basic earnings (loss) per share by dividing net earnings (loss) available to common shareholders by the weighted average
number of common shares outstanding during the reporting period. Diluted earnings per share is calculated similarly but reflects
the potential impact of shares issuable upon the conversion or exercise of our outstanding convertible Preferred Stock, convertible
notes payable, stock warrants and other commitments to issue Common Stock, except where the impact would be anti-dilutive, as
defined in GAAP.
The
calculation of diluted earnings per share also reflects an adjustment to net earnings for the potential reduction to a reporting
period’s interest expense, net of applicable income tax, that would result if the Company’s convertible notes payable
were converted at the beginning of such reporting period.
The
following table sets forth the computations of basic and diluted earnings (loss) per share for the periods indicated:
|
|
Fiscal Year Ended
|
|
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Net earnings (loss)
|
|
$
|
(1,235,021
|
)
|
|
$
|
2,788,605
|
|
After-tax interest expense adjustment
|
|
|
-
|
|
|
|
37,414
|
|
Net earnings (loss), if-converted basis
|
|
$
|
(1,235,021
|
)
|
|
$
|
2,826,019
|
|
Weighted average basic shares
|
|
|
172,046,517
|
|
|
|
131,472,281
|
|
Dilutive securities:
|
|
|
|
|
|
|
|
|
Convertible Preferred Stock
|
|
|
-
|
|
|
|
46,125,389
|
|
Convertible notes
|
|
|
-
|
|
|
|
39,993,730
|
|
Stock warrants
|
|
|
-
|
|
|
|
22,232,572
|
|
Weighted average diluted shares
|
|
|
172,046,517
|
|
|
|
239,823,972
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.01
|
)
|
|
$
|
0.02
|
|
Diluted
|
|
$
|
(0.01
|
)
|
|
$
|
0.01
|
|
The
following potentially dilutive securities and instruments were outstanding as of March 31, 2021 but excluded from the table above
because their impact would be anti-dilutive:
Convertible Preferred Stock
|
|
|
20,879,530
|
|
Convertible notes payable
|
|
|
10,406,100
|
|
Stock warrants
|
|
|
34,128,212
|
|
Total potential incremental shares
|
|
|
65,413,842
|
|
NOTE
5 – NOTES RECEIVABLE
In
January 2021, the Company and 1044PRO, LLC (“1044 PRO”) entered into a Funding Agreement pursuant to which the Company
agreed to provide to 1044 PRO a $250,000 revolving credit line and loaned $204,879 to 1044 PRO under the credit line. Borrowings
under the credit line are payable in monthly installments in amounts determined by the amount of each cash advance. At March 31,
2021, loans of $94,600 are outstanding, net of an allowance for the impairment losses of $94,599. In connection with the loan,
the Company acquired a 10% equity interest in 1044 PRO and a security interest in 1044 PRO’s cash receipts and in substantially
all 1044 PRO’s assets.
In
the fiscal year ended April 30, 2020, the Company received a promissory note for $58,047 from a prior merchant payment processor
in connection with amounts owed to the Company. At March 31, 2021, and April 30, 2020, $0 and $58,047, respectively, was outstanding.
In
the fiscal year 2019, the Company received a promissory note for $106,404 from a prior merchant payment processor in connection
with amounts owed to the Company. At March 31, 2021, and April 30, 2020, the amounts of $0 and $60,000, respectively, is outstanding,
net of an allowance for the impairment losses of $20,000 and $46,404, respectively.
In
the fiscal year ended March 31, 2021, and April 30, 2020, the Company recognized impairment losses of $114,599 and $46,404 in
connection with the notes receivable discussed above.
NOTE
6 – OTHER CURRENT ASSETS
Other
current assets consist of the following:
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Inventory-related deposits
|
|
$
|
1,845.722
|
|
|
$
|
-
|
|
Employee advances
|
|
|
320,631
|
|
|
|
554,787
|
|
Prepaid freight and other expenses
|
|
|
210,665
|
|
|
|
404,089
|
|
Right to recover asset
|
|
|
26,616
|
|
|
|
76,103
|
|
|
|
$
|
2,403,634
|
|
|
$
|
1,034,979
|
|
Prepaid
freight and other expenses consist of payments for goods and services (such as freight, trade show expenses and insurance premiums)
which are expected to be realized in the next operating cycle. Right to recover asset is associated with our customers’
right of return and is expected to be realized in one year or less. As of March 31, 2021, and April 30, 2020, employee advances
include $320,631 and $554,630 due from an employee in connection with payroll tax obligations associated with the exercise of
compensatory stock warrants.
NOTE
7 - PROPERTY AND EQUIPMENT
Property and equipment consist of the following:
|
|
|
|
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Computer software
|
|
$
|
734,510
|
|
|
$
|
19,156
|
|
Furniture and fixtures
|
|
|
230,685
|
|
|
|
224,239
|
|
Computer equipment
|
|
|
165,767
|
|
|
|
136,337
|
|
Leasehold improvements
|
|
|
106,877
|
|
|
|
106,877
|
|
Office equipment
|
|
|
31,652
|
|
|
|
31,652
|
|
Total property and equipment
|
|
|
1,269,491
|
|
|
|
518,261
|
|
Accumulated depreciation and amortization
|
|
|
(381,541
|
)
|
|
|
(219,878
|
)
|
Property and equipment, net
|
|
$
|
887,950
|
|
|
$
|
298,383
|
|
Depreciation
and amortization expense for the fiscal year ended March 31, 2021 and April 30, 2020 was $161,663 and $128,860, respectively.
During
the fiscal year ended March 31, 2021, the Company capitalized $715,354 in computer software in connection with upgrades to its
information technology systems placed in service. In addition, during the fiscal year ended March 31, 2021, the Company incurred
$163,106 in capitalizable costs primarily in connection with leasehold improvements for office facilities and ongoing upgrades
to its information technology systems yet to be placed in service. These costs are reported in other assets in our consolidated
balance sheets until the related assets are placed in service.
NOTE
8 - NOTES PAYABLE
In
May 2020, the Company was granted a loan (the “PPP Loan”) by a commercial bank in the amount of $1,040,400, pursuant
to the Paycheck Protection Program features of the Coronavirus Aid, Relief, and Economic
Security Act of 2020 (the “CARES Act”). The PPP Loan is evidenced by a promissory note, matures on May 13,
2022 and bears interest at an annual rate of 1.0%. The PPP Loan may
be prepaid without penalty, at the option of the Company, at any time prior to maturity. Proceeds from loans granted under the
CARES Act are intended to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain
other qualified costs (“qualifying expenses”). The Company used the loan proceeds for qualifying expenses.
The
Company’s borrowings under the PPP Loan
are eligible for loan forgiveness, subject to certain limiting conditions, if used for qualifying
expenses incurred during the “covered period,” as defined in the CARES Act. Under the terms of the PPP Loan, the Company’s
indebtedness, after any such loan forgiveness, is payable in equal monthly installments, with all amounts due and payable by March
13, 2022. At March 31, 2021, loan principal in the amount of $1,040,400, excluding
accrued but unpaid interest of $8,922, is outstanding. As more fully described in Note 18
– “Subsequent Events,” in May 2021, the Company was notified by the lender that the Company’s obligations
under the PPP Loan have been forgiven effective May 25, 2021.
NOTE
9 - ACCRUED AND OTHER CURRENT LIABILITIES
Accrued
and other current liabilities consist of the following:
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Accrued severance expense
|
|
$
|
700,000
|
|
|
$
|
-
|
|
Payroll and employee benefits
|
|
|
523,454
|
|
|
|
1,199,950
|
|
Settlement liability, current portion
|
|
|
376,921
|
|
|
|
1,652,126
|
|
Lease liability, current portion
|
|
|
373,398
|
|
|
|
476,950
|
|
Accrued interest payable
|
|
|
29,848
|
|
|
|
15,419
|
|
Other operational accruals
|
|
|
453,012
|
|
|
|
425,166
|
|
|
|
$
|
2,473,412
|
|
|
$
|
3,769,611
|
|
Lease
liability, current portion, represent obligations due withing one year under operating leases for office space, automobiles, and
office equipment. See Note 11 – “Leases” below for more information.
NOTE
10 - CONVERTIBLE NOTES PAYABLE
Convertible
notes payable consists of the following:
|
|
|
|
Conversion Price
|
|
|
|
|
Issuance Date
|
|
Maturity Date
|
|
(per share)
|
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
October 2017
|
|
October 2022
|
|
$
|
0.15
|
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
April 2018
|
|
April 2021
|
|
$
|
0.01
|
|
|
|
100,000
|
|
|
|
100,000
|
|
Total convertible notes payable
|
|
150,000
|
|
|
|
150,000
|
|
Less: unamortized debt discount and deferred financing fees
|
|
15,607
|
|
|
|
34,255
|
|
|
|
134,393
|
|
|
|
115,745
|
|
Less: current portion of convertible notes payable
|
|
99,631
|
|
|
|
90,157
|
|
Long-term convertible notes payable
|
$
|
34,762
|
|
|
$
|
25,588
|
|
The
Company’s convertible notes are convertible, at the option of the holder, into shares of the Company’s Common Stock
at the conversion prices shown above. Borrowings on the October 2017 convertible note bears interest at the annual rate of 12%.
The April 2018 convertible note is non-interest bearing.
In
October 2017, the Company issued a Convertible Promissory Note in the principal amount of $50,000 (the “Note”) to HWH International,
Inc (“HWH” or the “Holder”). HWH is affiliated with Chan Heng Fai Ambrose, who in April 2020 became a Director
of the Company. The Note is convertible into 333,333 shares of the Company’s Common Stock. Concurrent with issuance of the Note,
the Company issued to HWH a detachable warrant to purchase up to an additional 333,333 shares of the Company’s Common Stock, at
an exercise price of $0.15 per share. Under the terms of the Note and the detachable stock warrant, the Holder is entitled to certain
financing rights. If the Company enters into more favorable transactions with a third-party investor, it must notify the Holder and may
have to amend and restate the Note and the detachable stock warrant to be identical. HWH has informed the Company that it believes that
during the term of the Note, the Company has granted more favorable financing terms to third-party lenders. As of the date of this Transition
Report, the Company and HWH are engaged in negotiations aimed at addressing HWH’s concerns. Accordingly, and as a result of
these negotiations, the conversion price shown on the table above and other terms of the note are subject to change.
In
the fiscal year ended April 30, 2020, the Company and the holder of the Company’s convertible note dated April 13, 2018
(the “April 2018 Note”) entered into an amendment to the underlying promissory note. Pursuant to the amendment, the
parties extended the maturity date of the note to April 2021. In addition, after giving effect to the amendment, the April 2018
Note is non-interest bearing. All other terms of the April 2018 Note remain unchanged. The Company recognized a gain of $13,972
in connection with this modification of debt.
In
the fiscal year ended March 31, 2021, and April 30, 2020, interest expense associated with the Company’s convertible notes
was $5,507 and $47,360, respectively, excluding amortization of debt discounts and deferred financing fees of $18,647 and $14,151.
These amounts are included in interest expense, net, in our consolidated statements of operations.
NOTE
11 – LEASES
The
Company leases space for its corporate headquarters, additional office and warehouse space, automobiles, and office and other
equipment, under lease agreements classified as operating leases. The Company’s real estate lease agreements have a remaining
term of one year or less, offer the Company customary renewal options, and contain provisions for customary common area maintenance
(CAM) assessments by the lessor. The Company’s leases for automobiles, and office and other equipment, have remaining terms
of one to two years. See Note 2 – “SIGNIFICANT ACCOUNTING POLICIES – Lease Accounting” for more information.
For the fiscal years ended March 31, 2021 and April 30, 2020, rent expense in connection with all our leases was $495,272 and
$637,876, respectively.
The
following information pertains to the Company’s leases as of the balance sheet dates indicated:
Assets
|
|
Classification
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Operating leases
|
|
Right-of-use assets, net
|
|
$
|
428,075
|
|
|
$
|
800,381
|
|
Total lease assets
|
|
|
|
$
|
428,075
|
|
|
$
|
800,381
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
Accrued and other current liabilities
|
|
$
|
373,398
|
|
|
$
|
476,950
|
|
Operating leases
|
|
Lease liability, long-term
|
|
|
77,810
|
|
|
|
343,948
|
|
Total lease liabilities
|
|
|
|
$
|
451,208
|
|
|
$
|
820,898
|
|
For
the fiscal years ended March 31, 2021 and April 30, 2020, expense pertaining to the Company’s leases is as follows:
Lease cost
|
|
Classification
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Operating lease cost
|
|
General and administrative expenses
|
|
$
|
495,272
|
|
|
$
|
637,876
|
|
Operating lease cost
|
|
Depreciation and amortization
|
|
|
-
|
|
|
|
-
|
|
Operating lease cost
|
|
Interest expense, net
|
|
|
-
|
|
|
|
-
|
|
Total lease cost
|
|
|
|
$
|
495,272
|
|
|
$
|
637,876
|
|
The
Company’s lease liabilities are payable as follows:
Twelve months ending March 31,
|
|
|
|
|
2022
|
|
|
$
|
373,398
|
|
2023
|
|
|
|
77,810
|
|
2024-2026
|
|
|
|
-
|
|
Thereafter
|
|
|
|
-
|
|
Total lease liability
|
|
|
$
|
451,208
|
|
NOTE
12 – INCOME TAXES
The
Company is an emerging growth company and, prior to its fiscal quarter ended October 31, 2018, had not generated pre-tax earnings.
Prior to its fiscal year ended April 30, 2020, the Company had not recognized a provision for (benefit from) income taxes. See
Note 2 – “SIGNIFICANT ACCOUNTING POLICIES – Income Taxes” for more information.
For
the fiscal years ended March 31, 2021, and April 30, 2020, our consolidated provision for (benefit from) income taxes is as follows:
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Current:
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
(326,121
|
)
|
|
$
|
2,020,305
|
|
State
|
|
|
268,473
|
|
|
|
113,714
|
|
Total current
|
|
|
(57,648
|
)
|
|
|
2,134,019
|
|
Deferred:
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(536,861
|
)
|
|
|
(1,649,018
|
)
|
State
|
|
|
|
|
|
|
-
|
|
Total deferred
|
|
|
(536,861
|
)
|
|
|
(1,649,018
|
)
|
Total consolidated income tax provision (benefit)
|
|
$
|
(594,509
|
)
|
|
$
|
485,001
|
|
For
the fiscal years ended March 31, 2021 and April 30, 2020, our effective income tax rate reconciliation is as follows:
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Federal statutory rate
|
|
|
21.0
|
%
|
|
|
21.0
|
%
|
State income taxes and franchise tax
|
|
|
(11.6
|
)
|
|
|
3.5
|
%
|
Prior period adjustments
|
|
|
45.6
|
|
|
|
-
|
|
Change in valuation allowance for NOL carry-forwards
|
|
|
(5.3
|
)
|
|
|
-
|
|
Effect of change in uncertain tax positions
|
|
|
(49.4
|
)
|
|
|
-
|
|
Stock warrant forfeitures and other items
|
|
|
32.2
|
|
|
|
(9.7
|
)%
|
Effective income tax rate
|
|
|
32.5
|
%
|
|
|
14.8
|
%
|
As
of March 31, 2021, and April 30, 2020, our deferred tax asset (liability) is as follows:
Deferred tax assets:
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Share-based compensation
|
|
$
|
873,970
|
|
|
$
|
1,098,622
|
|
Accruals and reserves not currently deductible
|
|
|
247,347
|
|
|
|
550,396
|
|
Impairment of investments and inventory
|
|
|
674,112
|
|
|
|
-
|
|
Other
|
|
|
77,741
|
|
|
|
-
|
|
Total deferred tax assets
|
|
|
1,873,170
|
|
|
|
1,649,018
|
|
Total deferred tax liability
|
|
|
-
|
|
|
|
-
|
|
Total consolidated deferred tax assets, net
|
|
$
|
1,873,170
|
|
|
$
|
1,649,018
|
|
Deferred
tax assets of $1,873,170, as of March 31, 2021, expire at various dates beginning in 2024. During the fiscal year ended March
31, 2021, the Company recognized, in the aggregate, $91,931 in deferred income tax benefits in connection with certain foreign
start-up operation. In addition, the Company recognized a valuation allowance of $91,931 in connection with the associated deferred
tax assets, since these star-up operations do not yet have a history of earnings and profits. As of March 31, 2021, and April
30, 2020, there were no other valuation allowances required in connection with our deferred tax assets.
For
the fiscal year ended March 31, 2021, the Company has adopted the comprehensive model for how an entity should recognize, measure,
present, and disclose in its financial statements uncertain tax positions that it has taken or expects to take on a tax return,
as codified in ASC Topic 740. Accordingly, the Company recognizes in its financial statements the impact of tax positions that
meet a “more likely than not” threshold, based on the technical merits of the position. The tax benefits recognized
in the financial statements from such a position that should be measured based on the largest benefit that has a greater than
fifty percent likelihood of being realized upon ultimate settlement. As of March 31, 2021, the company recorded $570,311 in other
current liabilities related to uncertain income tax positions. At March 31, 2021, the Company had unrecognized tax benefits of
$570,311 that, if recognized, would impact the Company’s effective tax rate.
A
reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows for the years ended March 31, 2021
and April 30, 2020:
|
|
Fiscal Year Ended
|
|
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Beginning Balance
|
|
$
|
-
|
|
|
$
|
-
|
|
Additions for tax positions related to the current year
|
|
|
-
|
|
|
|
-
|
|
Additions for tax positions of prior years
|
|
|
570,311
|
|
|
|
-
|
|
Reductions of tax positions of prior years
|
|
|
-
|
|
|
|
-
|
|
Settlement
|
|
|
-
|
|
|
|
-
|
|
Ending Balance
|
|
$
|
570,311
|
|
|
$
|
-
|
|
The
company recognizes interest and/or penalties related to uncertain tax positions in current income tax expense. For the year ended
March 31, 2021, the Company had accrued interest and penalties of $334,332 in the consolidated balance sheet, all of which was
expensed in the consolidated statement of operations for March 31, 2021. Although it is not reasonably possible to estimate the
amount by which unrecognized tax benefits may increase or decrease within the next twelve months due to uncertainties regarding
timing of any examinations, the Company is evaluating alternatives that may impact the recognition of uncertain tax positions
within the next twelve months.
The
Company files federal income tax returns in the United States and files income tax returns in various state and foreign jurisdictions.
As of March 31, 2021, the Company’s income tax returns for the following tax years remained subject to examination by a
major tax jurisdiction:
Tax
Jurisdiction
|
|
Open
Years
|
United
States
|
|
2016
- 2020
|
NOTE
13 - RELATED PARTY TRANSACTIONS
Alchemist
Holdings, LLC
In
February 2020, the Company, Alchemist Holdings, LLC (“Alchemist”), and a former Company officer entered into a Settlement
Accommodation Agreement (the “Accommodation Agreement”) pursuant to which Alchemist and the former Company officer
agreed to transfer to the Company 22,683,864 shares of the Company’s Common Stock held by Alchemist, in settlement of certain
obligations to the Company. In addition, the Company, Alchemist, and the former Company officer entered into a Securities Escrow
Agreement (the “Escrow Agreement”). Under the terms of the Escrow Agreement, the Company acquired control of the 22,683,864
shares of the Company’s Common Stock to be transferred to the Company. In connection with Accommodation Agreement and Escrow
Agreement, the Company recognized a deemed dividend in the amount of $2.6 million for the difference between the fair value of
the 22,683,864 shares of the Company’s Common Stock on the effective date of such agreements, and the accounts receivable
settled. Under the terms of the Accommodation Agreement, Alchemist and the former Company officer also agreed to transfer to the
Company 15,625,000 shares of the Company’s Common Stock held by Alchemist, to offset certain legal and other expenses incurred
by the Company in connection with various related-party legal claims. Under the terms of the Escrow Agreement, the Company also
acquired control of the 15,625,000 shares of the Company’s Common Stock to be transferred to the Company. The Company has
recognized a deemed dividend in the amount of $937,500 for the difference between the fair value of the 15,625,000 shares of the
Company’s Common Stock and the settlement amount.
Pursuant
to the underlying agreements, all the shares of the Company’s Common Stock discussed in the preceding paragraph were to
be transferred to the Company at a time that the Company, in its sole discretion, would decide. The timing of the Company’s
decision was contingent on the resolution of certain disputes between Alchemist and the former Company officer, on one part, and
certain other parties, on the other, regarding control and operation of Alchemist. In the fiscal year ended March 31, 2021, after
resolution of such disputes, the Company and Alchemist caused the transfer to the Company, in the aggregate, of 38,308,864 shares
of the Company’s Common Stock then held by Alchemist, and the Company retired such redeemed shares. In connection with the
transfer of control over the shares of stock in February 2020, as discussed in the preceding paragraph, the Company had recognized
the acquisition of treasury stock in the amount of $1,532,355, the fair value of the underlying shares of stock at the time control
was transferred.
In
addition, in June 2020, the Company and the former Company officer entered into a Settlement Accommodation Agreement and an Amended
and Restated Founder Consulting Agreement pursuant to which the Company and the former officer agreed to settle all existing disputes
between them, the former officer agreed to continue to provide certain consulting services to the Company, and the Company agreed
to pay certain amounts to the former officer. The Company has recognized a settlement liability of $2.0 million in connection
therewith. At March 31, 2021, the settlement liability balance is $1.2 million.
Related
Party Sublease
The
Company subleases warehouse and office space from Alchemist. During the fiscal years ended March 31, 2021, and April 30, 2020,
rent expense associated with such sublease agreement was $84,918 and $91,980, respectively.
Document
Security Systems, Inc.
In
July 2020, the Company and Chan Heng Fai Ambrose, a Director of the Company, entered into a Stock Purchase and Share Subscription
Agreement (the “SPA Agreement”) pursuant to which Mr. Chan invested $3.0 million in the Company in exchange for 30.0
million shares of the Company’s Class A Common Stock and a fully vested Stock Warrant to purchase up to 10.0 million shares
of the Company’s Class A Common Stock at an exercise price of $0.20 per share. On the stock warrant issuance date, the closing
price for the Company’s Common Stock was $0.177 per share and the Company recognized a deemed dividend of $2.4 million.
Simultaneously with the SPA Agreement, Mr. Chan and Decentralized Sharing Systems, Inc. (“DSSI”), a subsidiary of
Document Security Systems, Inc.(“DSS”), and, together with DSS, a major shareholder of the Company, entered into an
Assignment and Assumption Agreement pursuant to which Mr. Chan assigned to DSS all interests in the SPA Agreement. In July 2020,
the Company issued 30.0 million shares of its Class A Common Stock to DSS, an “accredited investor” as defined in
the Securities Act, pursuant to the SPA Agreement. Under the terms of the SPA Agreement, the shares of Class A Common Stock issued
to DSS are subject to a one (1) year restriction. The Stock Warrant issued pursuant to the SPA Agreement expires on the third
anniversary from the issuance date, unless exercised earlier.
In
March 2021, the Company and DSS executed a Binding Letter of Intent pursuant to which DSS agreed to loan to the Company, directly
or through its subsidiaries, the aggregate principal amount of $30.0 million, subject to the parties entering into a definitive
loan agreement. In connection therewith, on April 5, 2021, the Company and DSSI entered into a Securities Purchase Agreement,
pursuant to which the Company issued: (a) a Convertible Promissory Note in the principal amount of $30.0 million (the “Note”)
in favor of DSSI, and (b) a detachable Warrant to purchase up to 150,000,000 shares of the Company’s Class A Common Stock,
at $0.22 per share, and DSSI loaned to the Company $30.0 million. Under the terms of the loan, the Company agreed to pay to DSSI
a loan Origination Fee of $3.0 million, payable in shares of the Company’s Class A Common Stock, at the rate of $0.20 per
share. The Note bears interest at the annual rate of 8% and matures on April 5, 2024, subject to certain acceleration provisions
upon the occurrence of an Event of Default, as defined in the Note. At any time during the term of the Note, all or part of the
Note, including principal, less unamortized prepaid interest, if any, plus any accrued interest and other fees can be converted
into shares of the Company’s Class A Common Stock at the rate of $0.20 per share, at the option of the holder. Interest
on the Note is pre-payable annually in cash or in shares of the Company’s Class A Common Stock, at the option of the Company,
except that interest for the first year is pre-payable in shares of the Company’s Class A Common Stock, at the rate of $0.20
per share. Accordingly, in April 2021, the Company issued to DSSI 27,000,000 shares of its Class A Common Stock, including 15,000,000
shares in payment of the loan Origination Fee discussed above and 12,000,000 shares in prepayment of interest for the first year.
As
of March 31, 2021, DSS and its affiliates owned 64.2 million shares of the Company’s Class A Common Stock, excluding 160.0
million shares issuable upon the exercise of warrants held by DSS, including the detachable Warrant issued on April 5, 2021, and
150.0 million shares issuable upon conversion of the Note discussed in the preceding paragraph. Shareholder approval will be required
to increase the number of shares of the Company’s Common Stock authorized to allow for the potential conversion of 100%
of the Note. Under the terms of the SPA Agreement, the Company has agreed to seek such shareholder approval on or before July
30, 2021.
Chan
Heng Fai Ambrose, Frank D. Heuszel, and John (“JT”) Thatch, each a Director of the Company, also serve on the Board
of Directors of DSS. Mr. Thatch also serves as President, CEO and Interim Chairman of the Board of Directors of the Company.
HWH
International, Inc.
In
October 2017, the Company issued a Convertible Promissory Note in the principal amount of $50,000 (the “Note”) to HWH International,
Inc (“HWH” or the “Holder”). HWH is affiliated with Chan Heng Fai Ambrose, who in April 2020 became a Director
of the Company. The Note is convertible into 333,333 shares of the Company’s Common Stock. Concurrent with issuance of the Note,
the Company issued to HWH a detachable stock warrant to purchase up to an additional 333,333 shares of the Company’s Common Stock,
at an exercise price of $0.15 per share. Under the terms of the Note and the detachable stock warrant, the Holder is entitled to certain
financing rights. If the Company enters into more favorable transactions with a third-party investor, it must notify the Holder and may
have to amend and restate the Note and the detachable stock warrant to be identical. HWH has informed the Company that it believes that
during the term of the Note, the Company has granted more favorable financing terms to third-party lenders. As of the date of this Transition
Report, the Company and HWH are engaged in negotiations aimed at addressing HWH’s concerns.
HWH World, Inc.
A subsidiary of the Company operating in South Korea subleases office
space from HWH World, Inc., a company affiliated with Chan Heng Fai Ambrose, a Director of the Company.
K
Beauty Research Lab. Co., Ltd
In
January 2021, the Company issued a purchase order to acquire skin care products manufactured by K Beauty Research Lab. Co., Ltd (“K
Beauty”), a Korean-based supplier of skin care products that is affiliated with Chan Heng Fai Ambrose, a Director of the Company.
In addition, in January 2021 and April 2021, the Company deposited $0.4 million and $2.2 million, respectively, for product to be purchased
from K Beauty. The Company’s affiliates operating in Asia intend to distribute skin care and other products in South Korea
and other countries, including skin care products procured from K Beauty, as part of the Company’s previously announced strategic
growth plans.
Bear
Bull Market Dividends, Inc.
In
July 2020, the Company, Bear Bull Market Dividends, Inc. (“BBMD”), a purported shareholder of the Company, Kenyatto
Montez Jones (“Jones”), and MLM Mafia, Inc. (“MLM”) entered into a Settlement Accommodation Agreement
[Including Stock Disposition And Release Provisions] (the “SAA”) pursuant to which the relevant parties agreed to
settle all prior disputes between the Company, on the one part, and BBMD and Jones, on the other, concerning the status of BBMD
as a valid shareholder of the Company, and the ownership, operation, management and control of the Company, all of which has been
the subject of various pending lawsuits. In addition, the parties agreed to dismiss such pending lawsuits and exchanged customary
mutual releases.
In
August 2020, as provided under the SAA, the Disputed Stock, as defined in the SAA, was converted into 25.0 million shares of the
Company’s Class A Common Stock (the “Converted Stock”). In addition, under the terms of the SAA and the related
Securities Escrow And Disposition Agreement, in August 2020, MLM purchased from BBMD 20.0 million shares of the Converted Stock
at the purchase price of $0.0525 per share (or $1,050,000). Further, as provided under the SAA and the related Securities Escrow
And Disposition Agreement, the Company repurchased from MLM 17.5 million shares of the Converted Stock at the repurchase price
of $0.0514 per share (or $899,500) in cash, and the Company retired the shares repurchased. After giving effect to these transactions,
BBMD remained the holder of 5.0 million shares of the Company’s Class A Common Stock and MLM remained the holder of 2.5
million shares of the Company’s Class A Common Stock.
NOTE
14 - STOCKHOLDERS’ EQUITY – CAPITAL STOCK
Preferred
Stock
The
Company’s Board of Directors (the “Board”) has authorized the issuance of up to 200,000,000 shares of Preferred
Stock, par value of $0.0001 per share. The Board may divide this authorization into one or more series, each with distinct powers,
designations, preferences, and rights.
Series
A Convertible Preferred Stock
The
Board has authorized the issuance of up to 100,000,000 shares of Series A Convertible
Preferred Stock (the “Series A Preferred Stock”). Shares of our Series A Preferred Stock are senior in rank to shares
of our Series C Preferred Stock. The affirmative vote of the holders of 86% of the issued and outstanding shares of our Series
A Preferred Stock is required for the Board: (i) to declare dividends upon shares of our Common Stock unless, with respect to
cash dividends, the shares of our Series A Preferred Stock are to receive the same dividend as the common shares, on an as converted
basis; (ii) to redeem the shares of our Series A Preferred Stock at a redemption price of $0.001 per share; (iii) to authorize
or issue additional or other capital stock that is junior or equal in rank to shares of our Series A Preferred Stock with respect
to the preferences as to distributions and payments upon the liquidation, dissolution, or winding up of the Company; and
(iv) to amend, alter, change, or repeal any of the powers, designations, preferences, and rights of our Series A Preferred Stock.
Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A
Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.001 per share before any payment or distribution
shall be made on our shares of Common Stock, or any other class of capital stock ranking junior to the Series A Preferred Stock.
For a period of 10 years from the date of issuance, the holders of the Series A Preferred Stock may elect to convert each share
of the Series A Preferred Stock into one share of the Company’s Common Stock. Each share of our Series A Preferred Stock
is entitled to one vote when voting as a class or together with the shares of our Common Stock.
In
the fiscal year ended April 30, 2020, the Company and 212 Technologies, LLC (“212 Technologies”) entered into a Release
and Settlement Agreement pursuant to which the parties, among other things rescinded a certain “Stakeholder & Investment
Agreement” dated May 21, 2017 and 212 Technologies returned 5,628,750 shares of the Company’s Series A Preferred Stock.
In July 2020, the Company retired these shares. During the fiscal year ended March 31, 2021 and April 30, 2020, stockholders converted
an aggregate of 21,750,000 shares and 10,400,000 shares, respectively, of the Company’s Series A Preferred Stock into an
equal number of shares of the Company’s Common Stock.
As
of March 31, 2021, 5,100,000 shares of the Company’s Series A Preferred Stock remain outstanding. As disclosed in the notes
to our consolidated financial statements for the fiscal year ended April 30, 2020, in the fiscal year 2019, the Company filed
suit against Research & Referral BZ and two other parties concerning breach of contract, fraud, and statutory fraud in a stock
transaction, violations of state securities laws and alter ego relating to a stock exchange/transfer transaction, involving the
Company’s stock. In April 2020, the court issued a Final Default Judgment in favor of the Company finding Research and Referral,
BZ liable for the Company’s claims of fraud in the inducement and statutory fraud in a stock transaction. Further, the court
ordered that the stock transaction be rescinded, and the Company’s stock be returned to the Company, and the matter has
been dismissed with prejudice. The shares of the Company’s Series A Preferred Stock reported in the Company’s financial
statements as of March 31, 2021 include 4,900,00 shares purportedly owned by Research & Referral BZ, pending cancellation
of the stock certificate when presented by Research & Referral BZ in the future.
Series
B Convertible Preferred Stock
The
Board has authorized the issuance of up to 10,000,000 shares of Series B Convertible
Preferred Stock (the Series B Preferred Stock”). Issued and outstanding shares of our Series B Preferred Stock, if any,
are senior in rank to shares of our Series A and Series C Preferred Stock. In August 2020, as more fully discussed in Note 13
above, BBMD, then the purported holder of 2,500,000 shares of the Company’s Series B Preferred Stock, converted such holdings
into 2,500,000 shares of the Company’s Class A Common Stock. In addition, in September 2020, the Company and Alchemist agreed
to convert 7,500,000 shares of the Company’s Series B Preferred Stock then held by Alchemist into 7,500,000 shares of the
Company’s Class A Common Stock. As of March 31, 2021, no shares of the Company’s Series B Preferred Stock remain outstanding.
Series
C Convertible Preferred Stock
The
Board has authorized the issuance of up to 10,000,000 shares of Series C Convertible Preferred Stock (the Series C Preferred Stock”).
Shares of our Series C Preferred Stock are junior in rank to the Series A and Series B Preferred Stock. The affirmative vote of
the holders of 86% of the issued and outstanding shares of our Series C Preferred Stock is required for the Board: (i) to declare
dividends upon shares of our Common Stock unless, with respect to cash dividends, the shares of our Series C Preferred Stock are
to receive the same dividend as the common shares, on an as converted basis; (ii) to redeem the shares of Series C Preferred Stock
at a redemption price of $0.001 per share; (iii) to authorize or issue additional or other capital stock that is junior or equal
in rank to our Series C Preferred Stock with respect to the preferences as to distributions and payments upon the liquidation,
dissolution, or winding up of the Company; and (iv) to amend, alter, change, or repeal any of the powers, designations, preferences,
and rights of the Series C Preferred Stock. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary
or involuntary, the holders of the Series C Preferred Stock are entitled to receive out of the assets of the Company the sum of
$0.001 per share before any payment or distribution shall be made on our shares of Common Stock, or any other class of capital
stock of the Company ranking junior to the Series C Preferred Stock. For a period of 10 years from the date of issuance, the holders
of the Series C Preferred Stock may elect to convert each share of Series C Preferred Stock into one share of the Company’s
Common Stock. Each share of our Series C Preferred Stock is entitled to one vote when voting as a class or together with shares
of our Common Stock.
During
the fiscal year ended March 31, 2021 and April 30, 2020, holders of 260,000 shares and 50,000 shares, respectively, of the Company’s
Series C Preferred Stock converted their holdings into an equal number of shares of the
Company’s Common Stock. During the fiscal year ended April 30, 2020, the Company issued 20,000 shares of its Series
C Preferred Stock in exchange for cash in the amount of $5,000, in connection with stock subscription agreements in the
ordinary course of its business. As of March 31, 2021, 3,230,000 shares of the Company’s Series C Preferred Stock remain
outstanding.
Common
Stock
The
Board has authorized the issuance of up to 500,000,000 shares of Class A Common Stock and up to 10,000,000 shares of Class B Common Stock,
each with a par value of $0.0001 per share. Holders of our Common Stock are entitled to dividends, subject to the rights of the holders
of other classes of capital stock outstanding having priority rights with respect to dividends. At the time of this report, no
shares of the Company’s Class B Common Stock remain outstanding. References to our “Common Stock” throughout this report
include our Class A Common Stock and Class B Common Stock, unless otherwise indicated or the context otherwise requires.
During
the fiscal year ended March 31, 2021, the Company issued 30,000,000 shares of its
Class A Common Stock and a fully vested Stock Warrant to purchase up to 10.0 million shares of the Company’s Class A Common
Stock, at the exercise price of $0.20 per share, to DSS in exchange for $3.0 million in cash (see Note 13 above). In addition,
the Company issued 10,000,000 shares of its Class A Common Stock to Robert Oblon, a co-founder of the Company, pursuant to the
Multi-Party Settlement Agreement discussed earlier. Further, during the fiscal year ended March 31, 2021, the Company issued 5,488,247
shares of its Class A Common Stock in connection with the exercise of warrants by Company employees and 2,339,000 shares of its
Class A Common Stock in connection with the exercise of warrants by independent distributors of the Company.
During
the fiscal year ended March 31, 2021, the holders of 10,000,000 shares of the Company’s Series B Preferred Stock and 10,000,000
shares of the Company’s Class B Common Stock converted their holdings into an aggregate of 20,000,000 shares of the Company’s
Class A Common Stock. In addition, during the fiscal year ended March 31, 2021: (a) as discussed above, BBMD, then the purported
holder of 20,000,000 shares of the Company’s Series A Preferred Stock, converted such holdings into 20,000,000 shares of
the Company’s Class A Common Stock, (b) holders of 1,750,000 shares of the Company’s Series A Preferred Stock converted
such holdings into an equal number of shares of the Company’s Class A Common Stock, and (c) holders of 260,000 shares of
the Company’s Series C Preferred Stock converted such holdings into an equal number of shares of the Company’s Class
A Common Stock.
As
discussed in Note 13 above, during the fiscal year ended March 31, 2021, the Company repurchased 17,500,000 shares of the Converted
Stock for cash and retired such repurchased shares, and the Company and Alchemist caused the transfer to the Company, in the aggregate,
of 38,308,864 shares of the Company’s Common Stock, and the Company retired such redeemed shares.
During
the fiscal year ended April 30, 2020, the Company issued 30,000 shares of its Class A Common
Stock for cash in the amount of $7,500 in connection with stock subscription agreements in the ordinary course of its business.
In addition, in the fiscal year ended April 30, 2020, the Company issued 215,325
shares of its Class A Common Stock in exchange for consulting services with fair
market value of $57,000. In addition, in the fiscal year ended April 30, 2020, holders of 10,400,000 shares of
the Company’s Series A Preferred Stock, and holders of 50,000 shares of the Company’s Series C Preferred Stock
converted their holdings into an equal number of shares of the Company’s Common Stock.
Further, in the fiscal year ended April 30, 2020, holders of the Company’s convertible promissory notes converted $28,000
in notes principal and/or accrued interest into 2,800,000 shares of the Company’s Class A Common Stock, pursuant to the
terms of the underlying debt instruments.
In
the fiscal year ended April 30, 2020, the Company issued 10,000,000 shares of its Class A Common Stock to an officer and director,
at an exercise price of $0.0001 per share, upon the exercise of derivative instruments granted in conjunction with an employment
agreement disclosed previously.
In
addition, in the fiscal year ended April 30, 2020, the Company repurchased in private transactions (and retired) 1,500,000 shares
of its Class A Common Stock.
As
of March 31, 2021, and April 30, 2020, 160,100,769
shares and 126,072,386 shares, respectively, of our Class A Common Stock remained issued and outstanding. As of March 31, 2021,
no shares of the Company’s Class B Common Stock remain outstanding. As of April 30, 2020, 10,000,000 shares of the Company’s
Class B Common Stock were outstanding.
NOTE
15 – STOCK-BASED COMPENSATION
In
the fiscal year ended March 31, 2021, and April 30, 2020, the Company awarded compensatory stock warrants to its officers and
employees (see Note 2 – “SIGNIFICANT ACCOUNTING POLICIES - Share-Based Payments” for more details). In addition,
in the fiscal years 2019 and 2021, the company issued stock warrants to its independent sales force. Further, the Company from
time to time, awards stock warrants to its consultants in exchange for services.
Stock
Warrants
Stock
Warrants Issued to Directors, Officers and Employees
In
the fiscal year ended March 31, 2021, and April 30, 2020, the Company issued to Company directors, officers and employees stock warrants
to purchase, in the aggregate, up to 29,200,000 shares and 32,000,000 shares, respectively, of its Common Stock. In the fiscal year
ended March 31, 2021, and April 30, 2020, the Company recognized expense of $3.6 million and $7.4 million, respectively, in connection
with those equity-based awards. Some of these stock warrants are exercisable at a variable exercise price (see Note 2 – “SIGNIFICANT
ACCOUNTING POLICIES - Share-Based Payments” for more details) pursuant to the related employment agreements.
As
discussed in Note 13, in July 2020, the Company and Chan Heng Fai Ambrose, a Director of the Company, entered into a Stock Purchase
and Share Subscription Agreement (the “SPA Agreement”) pursuant to which Mr. Chan agreed to invest $3.0 million in
the Company in exchange for 30.0 million shares of the Company’s Class A Common Stock and a fully vested Stock Warrant to
purchase up to 10.0 million shares of the Company’s Class A Common Stock at an exercise price of $0.20 per share. In July
2020, Mr. Chan assigned to DSS all interests in the SPA Agreement and the transactions contemplated in the SPA Agreement were
completed. Mr. Chan is a Director of DSS.
In
October 2017, the Company issued a convertible note in the principal amount of $50,000 to HWH International, Inc (“HWH”)
and a detachable stock warrant to purchase up to 333,333 shares of the Company’s Common Stock, at an exercise price of $0.15
per share. The Note is convertible into 333,333 shares of the Company’s Common Stock and expires in October 2022. HWH is
affiliated with Chan Heng Fai Ambrose, who in April 2020 became a Director of the Company.
The
following table summarizes the activity relating to the Company’s vested and unvested stock warrants held by Directors, Officers
and Employees:
|
|
Number of
Warrants
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Term
|
|
Outstanding at April 30, 2019
|
|
333,333
|
|
|
$0.15
|
|
|
3.5
|
|
Granted
|
|
|
32,000,000
|
|
|
|
0.0001
|
|
|
|
-
|
|
Exercised
|
|
|
(10,000,000
|
)
|
|
|
0.0001
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at April 30, 2020
|
|
|
22,333,333
|
|
|
$
|
0.002
|
|
|
|
4.2
|
|
Granted
|
|
|
39,200,000
|
|
|
|
0.13
|
|
|
|
-
|
|
Exercised
|
|
|
(9,000,000
|
)
|
|
|
0.0001
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
(18,125,000
|
)
|
|
|
0.0001
|
|
|
|
-
|
|
Outstanding at March 31, 2021
|
|
|
34,408,333
|
|
|
$
|
0.15
|
|
|
|
3.5
|
|
Less: unvested at March 31, 2021
|
|
|
11,625,000
|
|
|
$
|
0.15
|
|
|
|
3.0
|
|
Vested at March 31, 2021
|
|
|
22,783,333
|
|
|
|
0.15
|
|
|
|
3.0
|
|
Stock
Warrants Issued to Our Independent Sales Force
In
the fiscal year ended March 31, 2021 and April 30, 2020, the Company issued fully vested warrants to purchase up to 4,013,000 shares
and 628,800 shares, respectively, of its Common Stock to members of its independent sales force, with a fair value of $1.5 million and
$95,445, respectively. The warrants are exercisable for a period ranging from one to two years from the issuance date, at the exercise
price ranging from $0.01 per share to $0.25 per share. In the fiscal year ended March 31, 2021, warrants to purchase up to 2,066,600
shares of the Company’s Common Stock under the 2019 Sales-Related Warrants program expired or were otherwise terminated or forfeited.
See Note 2 – “SIGNIFICANT ACCOUNTING POLICIES - Sales Commissions” for more details.
The
following table summarizes the activity relating to the Company’s stock warrants held by members of the Company’s independent
sales force:
|
|
Number of
Warrants
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Term
|
|
Outstanding at April 30, 2019
|
|
|
3,761,800
|
|
|
$
|
0.04
|
|
|
|
3.6
|
|
Granted
|
|
|
628,800
|
|
|
|
0.25
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at April 30, 2020
|
|
|
4,390,600
|
|
|
$
|
0.04
|
|
|
|
2.5
|
|
Granted
|
|
|
4,013,000
|
|
|
|
0.01
|
|
|
|
-
|
|
Exercised
|
|
|
(2,339,000
|
)
|
|
|
0.01
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
(2,066,600
|
)
|
|
|
0.25
|
|
|
|
-
|
|
Outstanding at March 31, 2021
|
|
|
3,998,000
|
|
|
$
|
0.04
|
|
|
|
1.4
|
|
Stock
Warrants Held by Our Consultants
From
time to time, the Company has granted fully vested warrants to purchase shares of its Common Stock to its consultants in exchange for
services. The following table summarizes the activity relating to the Company’s stock warrants held by Company consultants:
|
|
Number of
Warrants
|
|
|
Weighted Average Exercise Price
|
|
|
Weighted Average Remaining Term
|
|
Outstanding at April 30, 2019
|
|
|
160,000
|
|
|
$
|
1.97
|
|
|
|
3.8
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at April 30, 2020
|
|
|
160,000
|
|
|
$
|
1.97
|
|
|
|
2.8
|
|
Granted
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Exercised
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
(60,000
|
)
|
|
|
0.25
|
|
|
|
-
|
|
Outstanding at March 31, 2021
|
|
|
100.000
|
|
|
$
|
3.00
|
|
|
|
1.0
|
|
The
following table summarizes additional information relating to all stock warrants outstanding and warrants exercisable as of March 31,
2021:
All Warrants Outstanding
|
|
|
All Warrants Exercisable
|
|
|
|
|
Weighted
Average Remaining
|
|
|
Weighted
Average
|
|
|
|
|
|
Weighted
Average
|
|
Number of
Shares
|
|
|
Contractual
life (in years)
|
|
|
Exercise
Price
|
|
|
Number of
Shares
|
|
|
Exercise
Price
|
|
3,000,000
|
|
|
|
6.4
|
|
|
$
|
0.0001
|
|
|
|
3,000,000
|
|
|
$
|
0.0001
|
|
21,075,000
|
|
|
|
3.7
|
|
|
$
|
0.15
|
|
|
|
9,450,000
|
|
|
$
|
0.14
|
|
10,000,000
|
|
|
|
2.3
|
|
|
$
|
0.20
|
|
|
|
10,000,000
|
|
|
$
|
0.20
|
|
2,180,000
|
|
|
|
2.2
|
|
|
$
|
0.14
|
|
|
|
2,180,000
|
|
|
$
|
0.14
|
|
1,674,000
|
|
|
|
.5
|
|
|
$
|
0.01
|
|
|
|
1,674,000
|
|
|
$
|
0.01
|
|
333,333
|
|
|
|
1.5
|
|
|
$
|
0.15
|
|
|
|
333,333
|
|
|
$
|
0.15
|
|
144,000
|
|
|
|
0.2
|
|
|
$
|
0.25
|
|
|
|
144,000
|
|
|
$
|
0.25
|
|
100,000
|
|
|
|
1.0
|
|
|
$
|
3.00
|
|
|
|
100,000
|
|
|
$
|
3.00
|
|
38,506,333
|
|
|
|
|
|
|
|
|
|
|
|
26,881,333
|
|
|
|
|
|
NOTE
16 - COMMITMENTS AND CONTINGENCIES
Contingencies
Acquisition-related
Contingencies
In
the fiscal year ended April 30, 2020, the Company and 212 Technologies, LLC (“212 Technologies”) entered into a Release and
Settlement Agreement (the “Settlement Agreement”) pursuant to which, among other things, the parties rescinded a certain
“Stakeholder & Investment Agreement” dated May 21, 2017, and 212 Technologies returned to the Company 5,628,750 shares
of the Company’s Series A Preferred Stock. In addition, in connection with the Settlement Agreement, the Company paid to 212 Technologies
the amount of $425,000 and dismissed with prejudice certain lawsuit it had previously filed, and the parties resolved all issues between
their respective companies. The Company recognized a loss of $425,000 in connection with the Settlement Agreement.
In
October 2017, the Company entered into a Share Exchange Agreement pursuant to which it acquired a 40% interest in 561 LLC in exchange
for 5,000,000 shares of its Series A Preferred Stock. Under the terms of the Share Exchange
Agreement, the sellers shall be entitled to an additional 2,500,000 shares of our Series
A Preferred Stock when both of the following conditions have been met: (a) one
year has passed from the Closing Date and (b) the closing bid price of the Company’s Common Stock equals or exceeds
$5.00 per share, as reported by OTC Markets. In accordance with GAAP, the Company has not recorded a liability in connection with this
contingency.
In
October 2017, the Company entered into a Share Exchange Agreement pursuant to which it acquired a 40% interest in America Approved Commercial
LLC (“AAC”). Under the terms of the Share Exchange Agreement,
the sellers shall be entitled to an additional 2,500,000 shares of the Company’s Series A Preferred Stock when both of the
following conditions have been met: (a) one year has passed from the Closing Date and
(b) the closing bid price of the Company’s Common Stock equals or exceeds $5.00 per share, as reported by OTC Markets. In accordance
with GAAP, the Company has not recorded a liability in connection with this contingency.
Legal
Proceedings – Related-Party Matters and Settlement Liability
In
the fiscal year ended April 30, 2020, the Company and the relevant subsidiaries; Jordan Brock (“Brock”), a Co-Founder of
the Company; Robert Oblon, a Co-Founder of the Company; certain officers and directors of the Company; and certain other corporate parties
entered into a Multi-Party Settlement Agreement pursuant to which the foregoing parties agreed to settle all prior disputes among them.
In addition, the Company, Alchemist and Brock entered into a Settlement Accommodation Agreement and an amendment to a previous founder’s
agreement pursuant to which the Company agreed to pay to Brock the sum of $1.4 million over time, and the Company recognized a settlement
liability for that amount. See Note 15 – “Related Party Transactions” above for more information. As of March 31, 2021,
and April 30, 2020, the Company has a remaining settlement liability of $1.2 million and $2.6 million in connection with all matters
discussed in this paragraph.
Legal
Proceedings – Other Matters
The
Company from time to time is involved in various claims and lawsuits incidental to the conduct of its business in the ordinary course.
We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position,
results of operations or cash flows.
|
(a)
|
Cause
No. 429-04618-2020; Kevin Young v. Elepreneurs Holdings, LLC, Elepreneurs U.S., LLC, Elevacity Holdings, LLC, Elevacity U.S.,
LLC, and Sharing Services Global Corporation f/k/a Sharing Services, Inc., pending in the 429th Judicial District
of Collin County, Texas. On September 18, 2020, a former employee filed a lawsuit against the Company and its affiliated entities
for breach a contract. The Company and its affiliated entities filed an answer denying the former employee’s claims. This matter
has been settled, but final administration of the settlement terms remains pending as of March 31, 2021.
|
|
|
|
|
(b)
|
Case
No. 4:20-cv-00946; Dennis Burback, Ken Eddy and Mark Andersen v. Robert Oblon, Jordan Brock, Jeff Bollinger, John Thatch, Four
Oceans Global, LLC, Four Oceans Holdings, Inc., Alchemist Holdings, LLC, Elepreneurs U.S., LLC, Elevacity U.S., LLC, Sharing Services
Global Corporation, Custom Travel Holdings, Inc., and Does 1-5, pending in the United States District Court for the Eastern District
of Texas. On December 11, 2020, three investors in Four Oceans Global, LLC filed a lawsuit against the Company, its affiliated entities,
and other persons and entities related to an investment made by the three investors in 2015. The Company and its affiliated entities
have filed an answer denying the three investors’ claims. This matter remains pending as of March 31, 2021.
|
|
|
|
|
(c)
|
Case
No. 4:20-cv-961; Crispina Meily v. Sharing Services Global Corporation f/k/a Sharing Services, Inc., pending in the United
States District Court for the Eastern District of Texas. On December 18, 2020, a former employee filed a lawsuit against the Company
for a statutory claim related to the former employee’s discharge from the Company. The Company filed an answer denying the
former employee’s claims. This matter remains pending as of March 31, 2021.
|
|
|
|
|
(d)
|
AAA
Ref. No. 01-20-0019-3907; Sharing Services Global Corporation, Elevacity Holdings, LLC, Elevacity U.S., LLC, Elepreneurs Holdings,
LLC and Elepreneurs U.S., LLC v. Robert Oblon, pending before the American Arbitration Association. On December 30, 2020, the
Company and its affiliated companies filed an arbitration complaint against Robert Oblon for breach of contract and a declaratory
judgment relating to the Multi-Party Settlement Agreement with Robert Oblon. This matter remains pending as of March 31, 2021.
|
|
|
|
|
(e)
|
Case
No. 4:20-cv-00989; Sharing Services Global Corporation, Elevacity Holdings, LLC, Elevacity U.S., LLC, Elepreneurs Holdings, LLC
and Elepreneurs U.S., LLC v. Robert Oblon, pending in the in the United States District Court for the Eastern District of Texas.
On December 30, 2020, the Company and its affiliated companies filed a lawsuit against Robert Oblon seeking injunctive relief relating
to the Multi-Party Settlement Agreement with Robert Oblon. This matter is a companion case to the AAA arbitration proceeding described
in paragraph (d) above and, while it remains pending as of March 31, 2021, further action in this case has been stayed by court order,
pending final adjudication of the referenced AAA arbitration proceeding.
|
|
(f)
|
Case
No. 4:21-cv-00026; Elepreneurs Holdings, LLC d/b/a Elepreneur, LLC, Elepreneurs U.S., LLC d/b/a Elepreneurs, LLC, and SHRG IP
Holdings, LLC v. Lori Ann Benson, Andrea Althaus and Lindsey Buboltz, pending in the United States District Court for the Eastern
District of Texas. On December 31, 2020, the Company filed suit against three former distributors and obtained injunctive relief
from the 429th Judicial District of Collin County, Texas. The lawsuit was removed by the three former distributors to
federal court. The Company subsequently obtained injunctive relief from the federal court. The matter remains pending as of March
31, 2021.
|
|
|
|
|
(g)
|
Case
No. 4:21-cv-00183; Sharing Services Global Corporation f/k/a Sharing Services, Inc., Elepreneurs Holdings, LLC n/k/a Elevacity
Holdings, LLC, Elepreneurs U.S., LLC n/k/a Elevacity U.S., LLC and SHRG IP Holdings, LLC v. AmplifeiIntl, LLC d/b/a HAPInss and HAPInssBrands,
LLC pending in the United States District Court for the Eastern District of Texas. On March 5, 2021, the Company and its affiliated
entities filed suit against a newly formed competitor for various claims including trademark infringement, trade secret violations,
unfair competition under state and federal law as well as tortious interference with contracts and business relationships. The matter
remains pending as of March 31, 2021.
|
|
|
|
|
(h)
|
On
December 4, 2019, Entrepreneur Media, Inc. filed a Notice of Opposition in response to the “Elepreneurs” trademark application
filed by SHRG IP Holdings, LLC, a wholly owned subsidiary of the Company. This opposition proceeding is now pending before the Trademark
Trial and Appeal Board of the United States Patent and Trademark Office. On April 13, 2020, SHRG IP Holdings, LLC filed an answer
to the Notice of Opposition. A scheduling order has been entered and the parties have exchanged initial disclosures. This matter
remains pending as of March 31, 2021.
|
|
|
|
|
(i)
|
The
Company engaged in preliminary discussions with various independent contractor distributors of its subsidiaries regarding a previously
reported dispute concerning the issuance of stock warrants based on the satisfaction of certain individual sales production metrics.
This matter remains pending as of March 31, 2021. See Note 2 - “SIGNIFICANT ACCOUNTING POLICIES - Sales Commissions”
for more information about the stock warrants liability associated with this matter.
|
|
|
|
|
(j)
|
The
Company engaged in preliminary discussions with an independent contractor distributor of its Subsidiary regarding a previously reported
dispute concerning an investment in ventures alleged to be related to the Company, and its Subsidiary operations. This matter remains
pending as of March 31, 2021. See Note 2 - “SIGNIFICANT ACCOUNTING POLICIES - Sales Commissions” for more information
about the stock warrants liability associated with this matter.
|
NOTE
17 - BUSINESS SEGMENT AND GEOGRAPHIC AREA INFORMATION
Business
Segments
As
of March 31, 2021, the Company, through its subsidiaries, markets and sells its products and services to consumers, through its independent
sales force and proprietary websites, and to its independent distributors. During the fiscal year March 31, 2021, and April 30, 2020,
approximately 99% and 98%, respectively, of our consolidated net sales are from our health and wellness products. The Company has determined
its reportable segments are: (a) the sale of health and wellness products, and (b) the sale of other products and services. The Company’s
determination of its reportable segments is based on how its chief operating decision maker manages the business.
The
Company’s segment information is as follows:
|
|
Fiscal Year Ended
|
|
|
|
March 31, 2021
|
|
|
April 30, 2020
|
|
Net sales
|
|
|
|
|
|
|
|
|
Health and wellness products
|
|
$
|
64,046,966
|
|
|
$
|
129,024,888
|
|
Other
|
|
|
764,185
|
|
|
|
2,365,018
|
|
Total net sales
|
|
$
|
64,811,151
|
|
|
$
|
131,389,906
|
|
Operating earnings (loss):
|
|
|
|
|
|
|
|
|
Segment gross profit:
|
|
|
|
|
|
|
|
|
Health and wellness products
|
|
$
|
45,997,828
|
|
|
$
|
91,831,033
|
|
Other
|
|
|
548,829
|
|
|
|
1,683,257
|
|
Total segment gross profit
|
|
|
46,546,657
|
|
|
|
93,514,290
|
|
Selling and marketing expenses
|
|
|
29,740,974
|
|
|
|
60,814,242
|
|
General and administrative expenses
|
|
|
18, 983,209
|
|
|
|
23,004,747
|
|
Consolidated operating earnings (loss)
|
|
$
|
(2,177,526
|
)
|
|
$
|
9,695,301
|
|
Total Assets:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
21,829,627
|
|
|
$
|
23,347,464
|
|
Corporate
|
|
|
442,686
|
|
|
|
1,229,894
|
|
Consolidated total assets
|
|
$
|
22,272,313
|
|
|
$
|
24,577,358
|
|
Payments for property and equipment:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
907,891
|
|
|
$
|
152,814
|
|
Corporate
|
|
|
6,445
|
|
|
|
8,043
|
|
Consolidated payments for property and equipment
|
|
$
|
914,336
|
|
|
$
|
160,857
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
155,085
|
|
|
$
|
122,417
|
|
Corporate
|
|
|
8,163
|
|
|
|
6,443
|
|
Consolidated depreciation and amortization
|
|
$
|
163,248
|
|
|
$
|
128,860
|
|
Geographic
Area Information
During
the fiscal year ended March 31, 2021, and April 30, 2020, 94% and 95%, respectively, of our consolidated net sales are to customers and
independent distributors located in the U.S. (based on the customer’s shipping address). The Company expects its sales to customers
and independent distributors located outside the U.S. to increase in the near future and plans to provide disclosure about its sales
by geographic area. Substantially all the Company’s assets are located in the U.S.
NOTE
18 - SUBSEQUENT EVENTS
As
more fully discussed in Note 13 above, on April 5, 2021, the Company and DSSI entered into a Securities Purchase Agreement (the “SPA
Agreement”), pursuant to which the Company issued: (a) a Convertible Promissory Note in the principal amount of $30.0 million (the
“Note”) in favor of DSSI, and (b) a detachable Warrant to purchase up to 150,000,000 shares of the Company’s Class
A Common Stock, at $0.22 per share. Under the terms of the loan, the Company agreed to pay to DSSI a loan Origination Fee of $3.0 million,
payable in shares of the Company’s Class A Common Stock, at the rate of $0.20 per share. Interest on the Note is pre-payable annually
in cash or in shares of the Company’s Class A Common Stock, at the option of the Company, except that interest for the first year
is pre-payable in shares of the Company’s Class A Common Stock, at the rate of $0.20 per share. Accordingly, in April 2021, the
Company issued to DSSI 27,000,000 shares of its Class A Common Stock, including 15,000,000 shares in payment of the loan Origination
Fee and 12,000,000 shares in prepayment of interest for the first year. Shareholder approval will be required to increase the number
of shares of the Company’s Common Stock authorized to allow for the potential conversion of 100% of the Note. Under the terms of
the SPA Agreement, the Company has agreed to seek such shareholder approval on or before July 30, 2021.
As
more fully discussed in Note 8 above, the Company’s borrowings under the PPP Loan
are eligible for loan forgiveness, subject to certain conditions, pursuant to the Coronavirus Aid,
Relief, and Economic Security Act of 2020. In May 2021, the Company was notified by the lender that the Company’s obligations
under the loan have been forgiven effective May 25, 2021. The loan forgiveness applies to all principal and interest accrued through
the loan forgiveness effective date.
NOTE
19 – SUPPLEMENTARY FINANCIAL INFORMATION
We
are a Smaller Reporting Company, as defined in Rule 12b-2 of the Exchange Act, and, accordingly, are not required to provide the supplementary
financial information otherwise required by Item 302, as amended.